Navigation Links
Elekta's Advanced Versa HD System to Begin Treating Cancer Patients at New Swiss Radiotherapy Clinic

VEVEY, Switzerland, March 27, 2013 /PRNewswire/ -- Cancer patients referred to Hopital Riviera's (Vevey, Switzerland) new radiotherapy clinic will soon benefit from the center's acquisition of Elekta's advanced new linear accelerator, Versa HD™. The system, currently being installed, will be the centerpiece of Hopital Riviera's modern radiotherapy department, which is scheduled to begin patient treatments in June. Hopital Riviera will maintain its collaborative clinical operations with Centre Hospitalier Universitaire Vaudois (CHUV, Lausanne).

Versa HD, unveiled by Elekta on March 1, is designed to be the most sophisticated, high-versatility treatment system, giving clinicians the flexibility to deliver conventional therapies to treat a wide range of small and large tumors throughout the body, while also enabling treatment of highly complex cancers that require extreme targeting precision. Treatment of the most challenging cases is facilitated by high-definition beam shaping, in addition to a groundbreaking high dose rate delivery mode.

"High-definition, high-speed beam shaping combined with high dose rate delivery makes Versa HD the ideal SBRT machine," says Oscar Matzinger , M.D., radiation oncologist at Hopital Riviera and CHUV. "Still, Versa HD will be our mainstay for basic and palliative treatments and support our future expansion of radiotherapy capabilities."

The first-ever combination of high-precision beam shaping plus high dose rate delivery in Versa HD will significantly improve the execution of SBRT (stereotactic body radiation therapy), Dr. Matzinger adds.

"An increasing share of radiation oncology patients in the future will be treated with SBRT, which historically has entailed relatively long treatment times," he says. "If we are talking about treating lung cancer or liver metastases, the faster we can deliver therapy the less chance for patient motion, and, in turn, the more precise therapy will be. The High Dose Rate mode within Versa HD will facilitate that."

"In addition, to achieve the best modulation of SBRT cases you need to have the most advanced MLC [multileaf collimator]," Dr. Matzinger adds. "With smaller and faster MLC leaves, dose modulation [IMRT] techniques like VMAT can help us be more precise in dose delivery and better protect organs-at-risk. The prospect of getting both of those features in a single delivery system makes it very promising for these advanced treatments."

The emergence of advanced, high-dose stereotactic therapies
"Some years ago, inoperable patients with limited metastatic burden were still treated with palliative care, but thanks to SBRT that trend has been changing. We can use aggressive local treatment in a bid to control their disease," Dr. Matzinger observes. "Versa HD has the potential to make SBRT even more precise and faster, making this technique a practical option, providing improved local control and better quality of life."

He adds that the speed of SBRT cases on Versa HD will not only provide clinical benefits for the patient, but it also will ensure these cases won't come at the expense of basic and palliative cases, which represent a large percentage Hopital Riviera's patient volume.

Breast and prostate packages
Hopital Riviera selected custom technology configurations for its Versa HD to support the requirements of treating breast and prostate cancers. Both packages are supported by Elekta's Clarity™ soft tissue visualization system to precisely define and target disease sites without invasive marker implants or the added ionizing radiation that some types of imaging require.

"Clarity seamlessly fuses with CT to allow us to better delineate the lumpectomy cavity in breast cancer patients – During treatment we can offer more precise targeting without the extra imaging dose to the patient," he says. "Similarly, we will use this system for transperineal imaging of the prostate to align the daily treatment with the prostate's position and eventually monitor that position during treatment. With Clarity, we can precisely localize the target to reduce treatment margins, and consequently, reduce toxicity to sensitive surrounding structures such as the rectum and bladder."

Hopital Riviera claims the distinction as the first medical center in Switzerland, and among the first in the world, to install a Versa HD system.

"We are very excited and proud to have one of the first Versa HD systems," Dr. Matzinger says. "We look forward to continued collaboration and development with Elekta."

For more information, visit

Versa HD is not available for sale or distribution in all markets. Elements of Versa HD are pending FDA 510(k) clearance.

For further information, please contact:
Johan Andersson Melbi , Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email:  
Time zone: CET: Central European Time

Michelle Joiner , Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email:
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website:


Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Krebspatienten an neuem Schweizer Zentrum für Strahlentherapie werden mit Elektas fortschrittlichem Versa HD-System behandelt
2. In Pretreated Advanced Renal Cell Carcinoma, Thought Leaders Opinions and Clinical Data Indicate that Tivopath Has Efficacy and Tolerability Advantages Over Currently Used Therapies
3. Advanced Devices for Injectable Drugs: Products, Players and Prospects - 2013 Report
4. EGEN, Inc. Announces a Phase I Clinical Trial for Advanced Ovarian Cancer
5. Oregon Health & Science University Receives Award For Leadership In Advanced Healthcare Technology Solutions
6. Animas Development of a First-Generation Closed Loop Insulin Delivery System Progresses With Data Presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference
7. India Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Others
8. Louisiana Pain Specialist Dr. Arnold Feldman Uses Advanced Techniques to Effectively Treat Herniated Disc
9. North America Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Other
10. Masimo Showcases Advanced, Noninvasive Patient Monitoring Technologies at Arab Health
11. Varian Equipment Selected to Equip New Cancer Center in Algeria and Enable More Advanced Radiotherapy Treatments for Patients
Post Your Comments:
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Italian therapeutic drug monitoring ...
(Date:11/25/2015)... , Nov. 26, 2015  The total global healthcare ... 7% over 2015-2016. Latin America has ... , (excluding Japan ), is second ... continues to face increased healthcare expenditure. In 2013-2014, total ... declined from 43.5% in 2008-2009 to 41.2% in 2013-2014. In ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma Services ... investment of at least $15.8  Million to expand ... Wilmington, NC . The expansion will provide ... meet the growing demands of the pharmaceutical and ... site expansion will provide up to 40,000 square ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions ... SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users of ... SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men and women ... healthcare organizations in the country. They have overseen financial turnarounds, shown commitment to ... the healthcare industry as a whole through their advocacy and professional efforts. , ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, ... choose to buy during the Black Friday and Cyber Monday massage chair sales ... search the Internet high and low to find the best massage chair deals, they ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... PRMA Plastic ... November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , ... wake up every day excited to rebuild lives and it’s an honor to have ...
(Date:11/25/2015)... OAK BROOK, Ill. (PRWEB) , ... November 25, ... ... sometimes larger and potentially more aggressive than those found on mammography, according to ... cases MRI findings of additional cancers not seen on mammography may necessitate a ...
Breaking Medicine News(10 mins):